These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35358697)

  • 1. Boosting the therapeutic efficacy of discoidal nanoconstructs against glioblastoma with rationally designed PEG-Docetaxel conjugates.
    Felici A; Schlich M; Di Mascolo D; Goldoni L; Lisa Palange A; Decuzzi P
    Eur J Pharm Biopharm; 2022 May; 174():90-100. PubMed ID: 35358697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docetaxel loaded oleic acid-coated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cells.
    Luo Y; Ling Y; Guo W; Pang J; Liu W; Fang Y; Wen X; Wei K; Gao X
    J Control Release; 2010 Oct; 147(2):278-88. PubMed ID: 20655966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Codelivery of GRP78 siRNA and docetaxel via RGD-PEG-DSPE/DOPA/CaP nanoparticles for the treatment of castration-resistant prostate cancer.
    Zhang X; He Z; Xiang L; Li L; Zhang H; Lin F; Cao H
    Drug Des Devel Ther; 2019; 13():1357-1372. PubMed ID: 31118572
    [No Abstract]   [Full Text] [Related]  

  • 4. μMESH-Enabled Sustained Delivery of Molecular and Nanoformulated Drugs for Glioblastoma Treatment.
    Di Mascolo D; Guerriero I; Pesce C; Spanò R; Palange AL; Decuzzi P
    ACS Nano; 2023 Aug; 17(15):14572-14585. PubMed ID: 37379253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actively targeted cetuximab conjugated gamma-poly(glutamic acid)-docetaxel nanomedicines for epidermal growth factor receptor over expressing colon cancer cells.
    Maya S; Sarmento B; Lakshmanan VK; Menon D; Jayakumar R
    J Biomed Nanotechnol; 2014 Aug; 10(8):1416-28. PubMed ID: 25016642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spherical polymeric nanoconstructs for combined chemotherapeutic and anti-inflammatory therapies.
    Lee A; Di Mascolo D; Francardi M; Piccardi F; Bandiera T; Decuzzi P
    Nanomedicine; 2016 Oct; 12(7):2139-2147. PubMed ID: 27247189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.
    Farokhzad OC; Cheng J; Teply BA; Sherifi I; Jon S; Kantoff PW; Richie JP; Langer R
    Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6315-20. PubMed ID: 16606824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.
    Hrkach J; Von Hoff D; Mukkaram Ali M; Andrianova E; Auer J; Campbell T; De Witt D; Figa M; Figueiredo M; Horhota A; Low S; McDonnell K; Peeke E; Retnarajan B; Sabnis A; Schnipper E; Song JJ; Song YH; Summa J; Tompsett D; Troiano G; Van Geen Hoven T; Wright J; LoRusso P; Kantoff PW; Bander NH; Sweeney C; Farokhzad OC; Langer R; Zale S
    Sci Transl Med; 2012 Apr; 4(128):128ra39. PubMed ID: 22491949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing the Pharmacological Properties of Discoidal Polymeric Nanoconstructs Against Triple-Negative Breast Cancer Cells.
    Ferreira M; Rizzuti IF; Palange AL; Barbato MG; Di Francesco V; Di Francesco M; Decuzzi P
    Front Bioeng Biotechnol; 2020; 8():5. PubMed ID: 32140459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo.
    Feng L; Wu H; Ma P; Mumper RJ; Benhabbour SR
    Int J Nanomedicine; 2011; 6():2545-56. PubMed ID: 22072889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate-targeted polymeric nanoparticle formulation of docetaxel is an effective molecularly targeted radiosensitizer with efficacy dependent on the timing of radiotherapy.
    Werner ME; Copp JA; Karve S; Cummings ND; Sukumar R; Li C; Napier ME; Chen RC; Cox AD; Wang AZ
    ACS Nano; 2011 Nov; 5(11):8990-8. PubMed ID: 22011071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer.
    Nagesh PKB; Johnson NR; Boya VKN; Chowdhury P; Othman SF; Khalilzad-Sharghi V; Hafeez BB; Ganju A; Khan S; Behrman SW; Zafar N; Chauhan SC; Jaggi M; Yallapu MM
    Colloids Surf B Biointerfaces; 2016 Aug; 144():8-20. PubMed ID: 27058278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization, and in vitro evaluation of docetaxel-loaded poly(lactic acid)-poly(ethylene glycol) nanoparticles for parenteral drug delivery.
    Liu D; Wang L; Liu Z; Zhang C; Zhang N
    J Biomed Nanotechnol; 2010 Dec; 6(6):675-82. PubMed ID: 21361132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy.
    Li L; Tang F; Liu H; Liu T; Hao N; Chen D; Teng X; He J
    ACS Nano; 2010 Nov; 4(11):6874-82. PubMed ID: 20973487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles from Gantrez® AN-poly(ethylene glycol) conjugates as carriers for oral delivery of docetaxel.
    Ruiz-Gatón L; Espuelas S; Huarte J; Larrañeta E; Martin-Arbella N; Irache JM
    Int J Pharm; 2019 Nov; 571():118699. PubMed ID: 31536764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of molecular and nano-therapies on brain tumor models in microfluidic devices.
    Martins AM; Brito A; Barbato MG; Felici A; Reis RL; Pires RA; Pashkuleva I; Decuzzi P
    Biomater Adv; 2023 Jan; 144():213227. PubMed ID: 36470174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docetaxel encapsulation in nanoscale assembly micelles of folate-PEG-docetaxel conjugates for targeted fighting against metastatic breast cancer in vitro and in vivo.
    Andisheh F; Oroojalian F; Shakour N; Ramezani M; Shamsara J; Khodaverdi E; Nassirli H; Hadizadeh F; Alibolandi M
    Int J Pharm; 2021 Aug; 605():120822. PubMed ID: 34182039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric micelles based on poly(ethylene glycol) block poly(racemic amino acids) hybrid polypeptides: conformation-facilitated drug-loading behavior and potential application as effective anticancer drug carriers.
    Gu PF; Xu H; Sui BW; Gou JX; Meng LK; Sun F; Wang XJ; Qi N; Zhang Y; He HB; Tang X
    Int J Nanomedicine; 2012; 7():109-22. PubMed ID: 22275827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmented efficacy of nano-formulated docetaxel plus curcumin in orthotopic models of neuroblastoma.
    Di Francesco M; Pastorino F; Ferreira M; Fragassi A; Di Francesco V; Palange AL; Celia C; Di Marzio L; Cilli M; Bensa V; Ponzoni M; Decuzzi P
    Pharmacol Res; 2023 Feb; 188():106639. PubMed ID: 36586642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.